PH26774A - Compounds having an anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy - Google Patents

Compounds having an anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy Download PDF

Info

Publication number
PH26774A
PH26774A PH37621A PH37621A PH26774A PH 26774 A PH26774 A PH 26774A PH 37621 A PH37621 A PH 37621A PH 37621 A PH37621 A PH 37621A PH 26774 A PH26774 A PH 26774A
Authority
PH
Philippines
Prior art keywords
estrogen
aromatase inhibitor
activity
dione
diene
Prior art date
Application number
PH37621A
Other languages
English (en)
Inventor
Walter Dr Elger
Sybille Dr Beier
Marianne Fahnrich
Beate Kosub
Krysztop Dr Chwalsz
Syed Hamiduddin Dr Hasan
Original Assignee
Elger, Walter, Dr.
Beier, Sybille, Dr.
Marianne Fahnrich
Beate Kosub
Chwalsz, Krysztop, Dr.
Hasan, Syed Hamiduddin, Dr.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elger, Walter, Dr., Beier, Sybille, Dr., Marianne Fahnrich, Beate Kosub, Chwalsz, Krysztop, Dr., Hasan, Syed Hamiduddin, Dr. filed Critical Elger, Walter, Dr.
Publication of PH26774A publication Critical patent/PH26774A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PH37621A 1987-10-01 1988-09-30 Compounds having an anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy PH26774A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873733478 DE3733478A1 (de) 1987-10-01 1987-10-01 Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore

Publications (1)

Publication Number Publication Date
PH26774A true PH26774A (en) 1992-09-28

Family

ID=6337559

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37621A PH26774A (en) 1987-10-01 1988-09-30 Compounds having an anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy

Country Status (14)

Country Link
US (2) US4888331A (enExample)
EP (1) EP0310541B1 (enExample)
JP (2) JP2620333B2 (enExample)
AT (2) ATE106730T1 (enExample)
AU (2) AU616208B2 (enExample)
CA (2) CA1330039C (enExample)
DE (3) DE3733478A1 (enExample)
DK (2) DK550088A (enExample)
ES (2) ES2055745T3 (enExample)
GR (1) GR3007225T3 (enExample)
IE (2) IE65165B1 (enExample)
IL (2) IL87886A (enExample)
PH (1) PH26774A (enExample)
ZA (2) ZA887378B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4329344A1 (de) * 1993-08-27 1995-03-02 Schering Ag Progesteronantagonistisch- und antiöstrogen wirksame Verbindungen für die Behandlung des Leiomyomata uteri
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
GB9410533D0 (en) * 1994-05-26 1994-07-13 Lynxvale Ltd In situ hybridisation and immuno-Chemical localisation of a growth factor
DE4426601A1 (de) * 1994-07-27 1996-02-01 Schering Ag Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
DE19706061A1 (de) 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
US6653297B1 (en) * 1997-07-03 2003-11-25 Medical College Of Hampton Roads Control of selective estrogen receptor modulators
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6399593B1 (en) * 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
EP1173213A1 (en) * 1999-05-04 2002-01-23 American Home Products Corporation Compositions containing benzimidazolones and progestogens
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
SI1173210T1 (en) * 1999-05-04 2005-02-28 Wyeth Contraceptive compositions containing antiprogestinic and progestinic
US6380178B1 (en) * 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
ATE301129T1 (de) 1999-05-04 2005-08-15 Strakan Int Ltd Androgen glykoside und die androgenische aktivität davon
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP2004510994A (ja) * 2000-10-06 2004-04-08 バイオメディシンズ，インコーポレイティド エストロゲン−感受性疾病の処理のための組み合わせ治療
DE60115274T2 (de) * 2000-10-18 2006-07-27 Schering Ag Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
US6599921B2 (en) 2001-02-22 2003-07-29 Nanodesign, Inc. Non-steroidal estrogen receptor ligands
UY27301A1 (es) * 2001-05-25 2003-02-28 Schering Ag Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la próstata
US20030013694A1 (en) * 2001-05-25 2003-01-16 Jens Hoffmann Use and compositions of antiprogestins for treatment of prostate diseases
GB0120147D0 (en) * 2001-08-17 2001-10-10 Metris Therapeutics Ltd Treatment method
DE10159217A1 (de) * 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
EP1603563A4 (en) * 2003-02-28 2007-08-22 Morgan Lee R RESONANCE MODULATOR FOR DIAGNOSIS AND THERAPY
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
US8685950B2 (en) * 2004-10-04 2014-04-01 Wayne State University Use of aromatase inhibitors for treatment of ectopic pregnancy
WO2008019048A1 (en) * 2006-08-04 2008-02-14 Meditrina Pharmaceuticals Use of aromatase inhibitors for thining the endometrium or treating menorrhagia
US7694688B2 (en) 2007-01-05 2010-04-13 Applied Materials, Inc. Wet clean system design
WO2009075838A2 (en) * 2007-12-10 2009-06-18 Meditrina Pharmaceuticals, Inc. Treatment of menorrhagia with aromatase inhibitor
US20100087402A1 (en) * 2008-09-29 2010-04-08 Vivus, Inc. Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
IE58836B1 (en) * 1984-08-02 1993-11-17 Labrie Fernand Pharmaceutical composition for combination therapy of hormone dependent cancers
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4732904A (en) * 1984-12-24 1988-03-22 Morgan Lee R Antiestrogenic hydrazones
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
FR2598083B1 (fr) * 1986-05-05 1989-12-29 Theramex Laboratoire Nouvelles compositions pharmaceutiques a action antiprogesteronique et leur procede d'obtention
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese

Also Published As

Publication number Publication date
AU616208B2 (en) 1991-10-24
AU2332288A (en) 1989-06-08
IE66335B1 (en) 1995-12-27
IE65165B1 (en) 1995-10-04
JP2656958B2 (ja) 1997-09-24
IE882954L (en) 1989-04-01
US5733902A (en) 1998-03-31
US4888331A (en) 1989-12-19
ZA887378B (en) 1989-05-30
ES2055745T3 (es) 1994-09-01
ATE106730T1 (de) 1994-06-15
JPH01106822A (ja) 1989-04-24
IL87885A0 (en) 1989-03-31
CA1329126C (en) 1994-05-03
DE3733478A1 (de) 1989-04-13
AU624082B2 (en) 1992-06-04
IL87885A (en) 1993-06-10
GR3007225T3 (enExample) 1993-07-30
ATE83149T1 (de) 1992-12-15
IL87886A (en) 1993-06-10
DE3850026D1 (de) 1995-07-06
AU2332188A (en) 1989-04-20
CA1330039C (en) 1994-06-07
DK550188D0 (da) 1988-09-30
JPH01106823A (ja) 1989-04-24
DE3876582D1 (de) 1993-01-21
EP0310541A1 (de) 1989-04-05
EP0310541B1 (de) 1992-12-09
ES2053795T3 (es) 1994-08-01
DK550088A (da) 1989-04-02
DK550188A (da) 1989-04-02
DK550088D0 (da) 1988-09-30
JP2620333B2 (ja) 1997-06-11
IE882953L (en) 1989-04-01
IL87886A0 (en) 1989-03-31
ZA887379B (en) 1989-05-30

Similar Documents

Publication Publication Date Title
PH26774A (en) Compounds having an anti-progestational and anti-estrogenic activities for induction of labor and for termination of pregnancy
CA2640520C (en) Extended cycle multiphasic oral contraceptive method
EP0912186B1 (en) Progestogen-anti-progestogen regimens
AU710819B2 (en) Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
US6506390B2 (en) Progestogen-anti-progestogen regimens
JPH08169833A (ja) 生物起原のエストロゲン成分を含む避妊／ホルモン置換のための医薬
EA016625B1 (ru) Способ контроля прорывных кровотечений при пролонгированном режиме приема гормональных контрацептивов
JP2007511533A (ja) 段階的エストロゲン避妊薬
US4670426A (en) Interruption of fertility in mammals by post-coital pills
Cedars Triphasic oral contraceptives: review and comparison of various regimens
US20050064031A1 (en) Combination contraceptive, kits that contain the latter, and a method that uses the latter
BG62877B1 (bg) Метод за контрол на женски фертилитет
MXPA02002186A (es) Mesoprogestinas (moduladores del receptor de progesterona) como un componente de los anticonceptivos femeninos.
USRE35724E (en) Contraception system and method
US5795881A (en) Combined use of an antigestagen and a progesterone synthesis inhibitor of the trilostane and epostane type
KR100271750B1 (ko) 경구 피임 및 월경 조절을 위한 에스트로겐/프로게스틴/안티프로게스틴 방법 및 키트
US20020177580A1 (en) Means and method for hormonal contraception
JP2716461B2 (ja) プロゲステロン合成阻害剤及び抗ゲスタゲンを含有する医薬及びその製法
MXPA02002190A (es) Mesoprogestinas (moduladores del receptor de progesterona como un componente de las composiciones para la terapia de reemplazo hormonal (hrt).
WO2002094280A1 (en) Means and method for hormonal contraception
AU2003206424B2 (en) Sequential estrogen/progesterone antagonist combination for hormone replacement therapy
CZ20013874A3 (cs) Farmaceutický prostředek
HK1019305B (en) Progestogen-anti-progestogen regimens
MXPA96004440A (en) Preparation of a pharmaceutical combination for oven contraception